Literature DB >> 28770271

[R1 resection of esophageal carcinoma].

I Gockel1, C Wittekind2.   

Abstract

The microscopic identification of residual tumor tissue in the oral or aboral resection margins (R1 resection) of esophageal specimens following oncologic esophageal resection, increases the risk of tumor recurrence and disease-related morbidity. Esophageal resection with its associated risks is only meaningful, if an R0 situation can be safely achieved. The relevance of microscopic involvement of the circumferential resection margin (CRM) in esophageal carcinoma in its different definitions by the British and the American Societies of Pathology has up to now never been investigated in a prospective study. According to the German S3 guideline, radiochemotherapy should be performed in a postoperatively proven R1 situation, which cannot be converted by a curative extended re-resection into an R0 situation or in unfavorable conditions for an extended re-resection, independent of neoadjuvant therapy. In the case of an R1 situation in the region of the CRM, an extended re-resection is not simply possible on account of the anatomical conditions with corresponding limitations by the aorta and the spinal column, in contrast to extensions of the re-resection orally or aborally.

Entities:  

Keywords:  Esophagectomy; Local recurrence; Prognosis; Radiochemotherapy; Re-resection

Mesh:

Year:  2017        PMID: 28770271     DOI: 10.1007/s00104-017-0469-1

Source DB:  PubMed          Journal:  Chirurg        ISSN: 0009-4722            Impact factor:   0.955


  34 in total

1.  Total three-stage oesophagectomy for cancer of the oesophagus.

Authors:  K C McKeown
Journal:  Br J Surg       Date:  1976-04       Impact factor: 6.939

2.  Significance of Microscopically Incomplete Resection Margin After Esophagectomy for Esophageal Cancer.

Authors:  Sheraz R Markar; Caroline Gronnier; Alain Duhamel; Arnaud Pasquer; Jérémie Théreaux; Mael Chalret du Rieu; Jérémie H Lefevre; Kathleen Turner; Guillaume Luc; Christophe Mariette
Journal:  Ann Surg       Date:  2016-04       Impact factor: 12.969

Review 3.  Surgical treatment of gastric cancer invading the oesophagus.

Authors:  F Bozzetti; P Bignami; L Bertario; S Fissi; M Eboli
Journal:  Eur J Surg Oncol       Date:  2000-12       Impact factor: 4.424

4.  Neoadjuvant chemoradiotherapy followed by surgery for esophageal adenocarcinoma: significance of microscopically positive circumferential radial margins.

Authors:  John A Harvin; Guy Lahat; Arlene M Correa; Jared Lee; Dipen Maru; Jaffer Ajani; Edith M Marom; James Welsh; Manoop S Bhutani; Garret Walsh; Jack Roth; Reza Mehran; Ara Vaporciyan; David Rice; Stephen Swisher; Wayne Hofstetter
Journal:  J Thorac Cardiovasc Surg       Date:  2011-12-14       Impact factor: 5.209

5.  Why do patients with weight loss have a worse outcome when undergoing chemotherapy for gastrointestinal malignancies?

Authors:  H J Andreyev; A R Norman; J Oates; D Cunningham
Journal:  Eur J Cancer       Date:  1998-03       Impact factor: 9.162

6.  Lymph node invasion might have more prognostic impact than R status in advanced esophageal adenocarcinoma.

Authors:  Magali Cabau; Guillaume Luc; Eric Terrebonne; Geneviève Belleanne; Véronique Vendrely; Antonio Sa Cunha; Denis Collet
Journal:  Am J Surg       Date:  2013-02-16       Impact factor: 2.565

7.  Adenocarcinoma of the gastroesophageal junction: influence of esophageal resection margin and operative approach on outcome.

Authors:  Andrew P Barbour; Nabil P Rizk; Mithat Gonen; Laura Tang; Manjit S Bains; Valerie W Rusch; Daniel G Coit; Murray F Brennan
Journal:  Ann Surg       Date:  2007-07       Impact factor: 12.969

8.  Rectal cancers with microscopic circumferential resection margin involvement (R1 resections): Survivals, patterns of recurrence, and prognostic factors.

Authors:  Gianpiero Gravante; David Hemingway; James Andrew Stephenson; David Sharpe; Ahmed Osman; Melissa Haines; Vafa Pirjamali; Roberto Sorge; Justin Ming Yeung; Michael Norwood; Andrew Miller; Kirsten Boyle
Journal:  J Surg Oncol       Date:  2016-07-07       Impact factor: 3.454

9.  Adjuvant Therapy for a Microscopically Incomplete Resection Margin after an Esophagectomy for Esophageal Squamous Cell Carcinoma.

Authors:  Bo Qiu; JiaXiang Li; Bin Wang; ZhiQiang Wang; Ying Liang; Peiqiang Cai; ZhaoLin Chen; MengZhong Liu; JianHua Fu; Hong Yang; Hui Liu
Journal:  J Cancer       Date:  2017-01-15       Impact factor: 4.207

10.  Three-dimensional conformal radiotherapy with concurrent chemotherapy for postoperative recurrence of esophageal squamous cell carcinoma: clinical efficacy and failure pattern.

Authors:  Yong Bao; ShiLiang Liu; QiChao Zhou; PeiQiang Cai; Simone Anfossi; QiaoQiao Li; YongHong Hu; MengZhong Liu; JianHua Fu; TieHua Rong; Qun Li; Hui Liu
Journal:  Radiat Oncol       Date:  2013-10-18       Impact factor: 3.481

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.